 Interaction dactinomycin tumor necrosis factor mesothelioma Cachexia oncolysis effective therapy human malignant mesothelioma susceptibility cytokines Recombinant human tumor necrosis factor alpha rHuTNF alpha vitro vivo antitumor activity human malignant mesothelioma cell line culture nude mice vitro direct antimesothelioma activity bromide assay combination transcription inhibitor dactinomycin AD cell metabolic activity control effects combination agents cells subcutaneous tumors nude mice vivo significant inhibition tumor growth rHuTNF alpha AD therapy combination marked cachexia doses component AD authors well-described vitro interaction AD rHuTNF vivo cachexia combination agents likely low therapeutic index malignant mesothelioma